author-photo

Georg Pfeiler

Medical University of Vienna

147

Papers

3231

Citations

Citation Trend

Filter By

Papers (107) Sort By

Journal Conference Others

Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)

2021 Breast Care
Show All
- Source
- Cite
- Save
Citations (0)
Persistence of ctDNA in breast cancer patients during neoadjuvant treatment is a significant predictor of poor tumour response.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Discrimination between 34 of 36 Possible Combinations of Three C>T SNP Genotypes in the MGMT Promoter by High Resolution Melting Analysis Coupled with Pyrosequencing Using A Single Primer Set

2021 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (0)
LBA12 PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (20)
More is not always better—what can be learned from the D-CARE trial

2020 Annals of Translational Medicine
- Georg Pfeiler
- Michael Gnant
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT3-06-01: Prevention and management of residual breast tissue following radical mastectomy and skin-sparing and nipple-sparing mastectomy in oncologic and high-risk breast cancer patients - A multicentre questionnaire study

2020 Cancer Research
- Christine Deutschmann
- Georg Pfeiler
Show All
- Source
- Cite
- Save
Citations (0)
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

2020 Genetics in Medicine
Show All
- Source
- Cite
- Save
Citations (34)
172P REACHAUT: Real-world study of first-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC)

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients

2019 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (5)
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

2019 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (9)